Products for Research Use Only
RegisterLogin

AURKA-IN-3

CAT: 0804-HY-175982Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-175982Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
AURKA-IN-3 (Compound AL8) is an irreversible covalent Aurora kinase A (AURKA) inhibitor with an IC50 value of 23.0 nM. AURKA-IN-3 inhibits the activation of cAMP signaling pathway and phospholipase C (PLC) signaling pathway mediated by AURKA, and reduces the autophosphorylation level of AURKA. AURKA-IN-3 is promising for research of malignant tumors associated with high AURKA expression (e.g., leukemia, lymphoma) [1].
UNSPSC
12352005
Target
Aurora Kinase
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Field of Research
Cancer
Smiles
O=C(NC1=CC=C(NC2=C(OC)C(C2=O)=O)C=C1)C3=CC=C(NC4=NC=C5C(C6=CC=C(Cl)C=C6C(C7=C(OC)C=CC=C7F)=NC5)=N4)C=C3OC
Molecular Formula
C38H28ClFN6O6
Molecular Weight
719.12
References & Citations
[1]Wang Z, et al. Cell-Active, Irreversible Covalent Inhibitors Targeting a Surface-Exposed Non-Catalytic Lysine on Aurora a Kinase by Using Squarate Chemistry. Angew Chem Int Ed Engl. 2025 Sep 26;64 (40) :e202510763.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Aurora A

Related Products

CatalogName
HY-161407AURKA-IN-1
HY-179574AURKA-IN-4
HY-162837AURKA against 1
HY-P701706AURKA, Human (sf9)
HY-158038AurkA allosteric-IN-1
HY-P702672-01AURKA, Human (sf9, GST)
HY-155464VEGFR-2/AURKA-IN-1
HY-175830PROTAC AURKA degrader 1
HY-RS01267Aurka Mouse Pre-designed siRNA Set A
HY-RS01266AURKA Human Pre-designed siRNA Set A

Alternative Products

CatalogName
GTR19273030-01AURKA-IN-3
E8EM1706-71AURKA
PVT14409pECMV-3-FLAG-AURKA Plasmid
GTR18237644-01AURKA Antibody
P9587POTB7-AURKA
556049-01AURKA (FITC)
OPPA01913-2UGAURKA Protein
GTR19061404AURKA Peptide

Popular Products